EXEL icon

Exelixis
EXEL

Upgrade to unlock
Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 26.8%
Negative

Positive
Zacks Investment Research
11 days ago
Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?
Positive
Zacks Investment Research
13 days ago
Here's Why Exelixis (EXEL) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Exelixis (EXEL) is a Strong Growth Stock
Positive
The Motley Fool
14 days ago
Exelixis: A Strong Contender in the Cancer Drug Market
Explore the exciting world of Exelixis (EXEL +2.24%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!
Exelixis: A Strong Contender in the Cancer Drug Market
Positive
Zacks Investment Research
27 days ago
Here's Why Exelixis (EXEL) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Exelixis (EXEL) is a Strong Value Stock
Positive
The Motley Fool
28 days ago
The Best Healthcare Stocks to Buy With $50 Right Now
Pfizer and Novo Nordisk look cheap in more ways than one. Pipeline progress could help improve their financial results.
The Best Healthcare Stocks to Buy With $50 Right Now
Negative
Zacks Investment Research
1 month ago
Exelixis (EXEL) Down 2.8% Since Last Earnings Report: Can It Rebound?
Exelixis (EXEL) reported earnings 30 days ago. What's next for the stock?
Exelixis (EXEL) Down 2.8% Since Last Earnings Report: Can It Rebound?
Positive
Zacks Investment Research
1 month ago
Here's Why Exelixis (EXEL) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Exelixis (EXEL) is a Strong Growth Stock
Neutral
Seeking Alpha
1 month ago
Exelixis, Inc. (EXEL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Exelixis, Inc. (EXEL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Exelixis, Inc. (EXEL) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Neutral
Seeking Alpha
1 month ago
Exelixis, Inc. (EXEL) Presents at The Citizens Life Sciences Conference 2026 Transcript
Exelixis, Inc. (EXEL) Presents at The Citizens Life Sciences Conference 2026 Transcript
Exelixis, Inc. (EXEL) Presents at The Citizens Life Sciences Conference 2026 Transcript
Neutral
Seeking Alpha
1 month ago
Exelixis, Inc. (EXEL) Presents at Leerink Global Healthcare Conference 2026 Transcript
Exelixis, Inc. (EXEL) Presents at Leerink Global Healthcare Conference 2026 Transcript
Exelixis, Inc. (EXEL) Presents at Leerink Global Healthcare Conference 2026 Transcript
See News Rankings